VeriMomVeriMom

copper heptapeptide-14 pantothenate é seguro durante a gravidez?

No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for this specific ingredient name; no peer‑reviewed reproductive or developmental toxicity data located in the cited sources. Topical copper‑peptide complexes and peptide salts generally have low dermal systemic bioavailability, so exposure from normal cosmetic use is expected to be negligible. Sources checked: ECHA Annex VI (harmonised CLP) = no entry; CIR/SCCS = no safety assessment for this exact ingredient; PubMed = no reproductive/developmental studies found.

Ingredientes
copper heptapeptide-14 pantothenate
SEM RISCOS CONHECIDOS
100
/100
0

Pregnancy-safe products containing copper heptapeptide-14 pantothenate

Related ingredients

Frequently asked questions

copper heptapeptide-14 pantothenate é seguro durante a gravidez?
No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for this specific ingredient name; no peer‑reviewed reproductive or developmental toxicity data located in the cited sources. Topical copper‑peptide complexes and peptide salts generally have low dermal systemic bioavailability, so exposure from normal cosmetic use is expected to be negligible. Sources checked: ECHA Annex VI (harmonised CLP) = no entry; CIR/SCCS = no safety assessment for this exact ingredient; PubMed = no reproductive/developmental studies found.
copper heptapeptide-14 pantothenate é seguro durante a amamentação?
No evidence of lactation/breastmilk transfer or reproductive hazard for this specific ingredient in the available regulatory and literature sources. Given the lack of systemic reproductive/toxicological data and expected low dermal absorption of peptide complexes, systemic exposure in lactating persons from cosmetic topical use is expected to be negligible. Sources checked: ECHA Annex VI, CIR, PubMed, CosIng, PubChem.
copper heptapeptide-14 pantothenate é seguro para a pele do bebê?
No infant‑specific toxicity or dermal absorption studies were identified. By default there is no evidence of reproductive or developmental hazard, but infant skin has higher permeability; while adult topical exposure is assessed as negligible, a precautionary modest increase in exposure score (e=1) is applied for 0–3 yr skin due to the immature barrier and higher surface‑area‑to‑weight ratio. No harmonised CLP flags or specific SCCS/CIR guidance for infant use were found.
Como o VeriMom pontua copper heptapeptide-14 pantothenate?
O VeriMom pontua copper heptapeptide-14 pantothenate em 100/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
Quais são as alternativas seguras a copper heptapeptide-14 pantothenate na gravidez?
Veja nossa lista curada de alternativas seguras a copper heptapeptide-14 pantothenate com base em função semelhante e classificação sem riscos conhecidos.

Verifique qualquer rótulo em 2 segundos

Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.

Aviso Médico

Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.

Tenha a experiência completa no app VeriMom